Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr284.60 DKK
Change Today -1.20 / -0.42%
Volume 299.6K
As of 7:01 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kurt Anker Nielsen M.Com.

AgeTotal Calculated CompensationThis person is connected to 7 board members in 2 different organizations across 13 different industries.

See Board Relationships
70kr200,000

Background*

Mr. Kurt Anker Nielsen, M.Com., served as Co-President and Chief Executive Officer of Novo A/S. He served as a Co-Chief Executive Officer of Novo A/S from December 2000 to September 2003. From 1996 to December 2000, he served as the Deputy Chief Executive Officer of Novo Nordisk A/S and also served as its Managing Director. From 1989 to December 2000, he served as the Chief Financial Officer of Novo Nordisk A/S; Executive Vice President of Corporate Finance from 1985 ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880

Denmark

Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Director

Education*

MS 1972
Copenhagen Business School
BA
Copenhagen Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensationkr200,000
Total Calculated Compensationkr200,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr284.60 DKK -1.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.